| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/03/2007 | US7198917 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198896 Immunoaffinity isolation of modified peptides from complex mixtures |
| 04/03/2007 | US7198892 Hepatitis-C virus type 4, 5 and 6 |
| 04/03/2007 | US7198791 Immunostimulants comprising epitopes from a malarial blood-stage protein |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198788 Administering pharmaceutical formulation comprising an anti-CD26 antibody, whereby the anti- CD26 antibody binds CD26 and arrests cell cycle for therapy of cancer |
| 04/03/2007 | CA2311602C Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 04/03/2007 | CA2236679C Differentiation-suppressive polypeptide |
| 04/03/2007 | CA2162397C Ligands for flt3 receptors |
| 04/03/2007 | CA2121559C Immunogenic artificial polypeptide |
| 04/03/2007 | CA2089661C Transgenic non-human animals capable of producing heterologous antibodies |
| 03/29/2007 | WO2007035624A1 Method for generating f(ab')2 antibody fragments |
| 03/29/2007 | WO2007035406A1 Antibodies to complementary peptides of thrombin or portions thereof |
| 03/29/2007 | WO2007034603A1 Marker gene for malignant brain tumor and use thereof |
| 03/29/2007 | WO2007034210A2 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 03/29/2007 | WO2007034177A1 Reagents and methods for the detection of transmissible spongiform encephalopathy |
| 03/29/2007 | WO2007012614A3 Novel anti-igf-ir antibodies and uses thereof |
| 03/29/2007 | WO2007009816A3 Plexin d1 as a target for tumor diagnosis and therapy |
| 03/29/2007 | WO2006138527A3 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 03/29/2007 | WO2006130834A3 IGGl ANTIBODIES WITH MUTATED FC PORTION FOR INCREASED BINDING TO FCRN RECEPTOR AND USES THEREOF |
| 03/29/2007 | WO2006110883A3 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 03/29/2007 | WO2006106336A3 Rat primers |
| 03/29/2007 | WO2006106331A3 Mouse primers |
| 03/29/2007 | WO2006105338A3 Fc VARIANTS WITH OPTIMIZED PROPERTIES |
| 03/29/2007 | WO2006100679A3 Recombinant antibodies against human type ii transglutaminase and uses thereof |
| 03/29/2007 | WO2006096491A3 Anti-ctla-4 antibody compositions |
| 03/29/2007 | WO2006089232A3 Monoclonal antibodies against cd30 lacking fucosyl residues |
| 03/29/2007 | WO2006072625A8 Anti-kir combination treatments and methods |
| 03/29/2007 | WO2005120558A3 Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease |
| 03/29/2007 | WO2005097211A3 Compositions as adjuvants to improve immune responses to vaccines and methods of use |
| 03/29/2007 | US20070074296 RTD receptor |
| 03/29/2007 | US20070074295 Schizophrenia related gene |
| 03/29/2007 | US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
| 03/29/2007 | US20070073044 Homogeneous preparations of il-28 and il-29 |
| 03/29/2007 | US20070073043 Process for producing humanized chimera antibody |
| 03/29/2007 | US20070073042 Novel MHC II associated peptides |
| 03/29/2007 | US20070073041 Human tumor necrosis factor receptor polypeptides |
| 03/29/2007 | US20070073039 Peptides that inhibit viral infections |
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072799 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 03/29/2007 | US20070072797 Epitopes |
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
| 03/29/2007 | US20070072282 Bovine adeno-associated viral (baav) vector and uses thereof |
| 03/29/2007 | US20070072269 Ubiquitin-specific protease occurring in the brain and DNA encoding the same |
| 03/29/2007 | US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog |
| 03/29/2007 | US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof |
| 03/29/2007 | US20070072249 Human cytokine and alpha-helix-containing polypeptides |
| 03/29/2007 | US20070072247 Methods and reagents for the analysis and purification of polysaccharides |
| 03/29/2007 | US20070072245 Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs |
| 03/29/2007 | US20070072240 Method for producing an in vitro expression library |
| 03/29/2007 | US20070072234 Protein capable of binding plasticizer |
| 03/29/2007 | US20070072228 ERCC2 polymorphisms |
| 03/29/2007 | US20070072218 A polynucleotide encoding a polypeptide having the amino acid sequence of SEQ ID NO:1, sequence operably linked to a heterologous promoter selected from hsp68, SV40, CMV, GAL4UAS, HSV and beta -actin; anticarcinogenic agents |
| 03/29/2007 | US20070072217 XAF genes and polypeptides: methods and reagents for modulating apoptosis |
| 03/29/2007 | US20070072177 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections |
| 03/29/2007 | US20070072176 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae |
| 03/29/2007 | US20070071764 conjugated polymer drug contains toxin protein and polyethylene glycol; treating autoimmune diseases, such as multiple sclerosis, type 1 diabetes, psoriasis, inflammatory bowel disease, dermatitis, rheumatoid arthritis, psoriasis; asthma, allergy, restinosis, fibrosis, scleroderma, glomerulonephritis |
| 03/29/2007 | US20070071763 Clostridium difficile focussed antibodies |
| 03/29/2007 | US20070071759 Antibody-immune cell ligand fusion protein for cancer therapy |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071750 Comprises heavy and light chain; treating envenomation by administering to neutralize in vivo effect |
| 03/29/2007 | US20070071749 Using cocktail comprising endothelial growth factor specific immunoglobulin and gemcitabine to treat and/or prevent pancreatic cancer |
| 03/29/2007 | US20070071748 Treatment with anti-vegf antibodies |
| 03/29/2007 | US20070071747 Use of TNFalpha inhibitor for treatment of erosive polyarthritis |
| 03/29/2007 | US20070071746 C/CLP antagonists and methods of use thereof |
| 03/29/2007 | US20070071745 Modified antigen binding molecules with altered cell signaling activity |
| 03/29/2007 | US20070071744 Agents which bind to epitopes of glycoprotein VI |
| 03/29/2007 | US20070071743 Novel human cell surface protein with immunoglobulin folds, BGS-19 |
| 03/29/2007 | US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria |
| 03/29/2007 | US20070071719 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 03/29/2007 | US20070071718 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of leukemia; immunotherapy |
| 03/29/2007 | US20070071714 Stem cell factor |
| 03/29/2007 | US20070071674 Polynucleotides encoding novel isoforms of IGSF9 |
| 03/29/2007 | DE102005046258A1 Immunosorbent for treating insulin resistance or metabolic syndrome comprises a polymeric support to which are attached ligands that specifically bind to interleukin-6 |
| 03/29/2007 | CA2623176A1 Protein a production and purification without using animal derived components |
| 03/29/2007 | CA2623016A1 Treatment of b cell diseases using anti-germline antibody binding agents |
| 03/28/2007 | EP1767641A1 Antigenic neisserial peptides |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767627A1 Anti-perp antibody |
| 03/28/2007 | EP1767625A1 Activity regulator for interferon producing cell |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767543A1 Novel bee venom polypeptides and methods of use thereof |
| 03/28/2007 | EP1766411A2 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 03/28/2007 | EP1766406A2 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 03/28/2007 | EP1766396A2 Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation |
| 03/28/2007 | EP1766393A2 Mhc bridging system for detecting ctl-mediated lysis of antigen presenting cells |
| 03/28/2007 | EP1766098A2 Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same |
| 03/28/2007 | EP1766096A2 Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectors |
| 03/28/2007 | EP1766094A2 Influenza virus vaccine composition and method of use |
| 03/28/2007 | EP1766093A2 Antibodies against clostridium difficile toxins and uses thereof |
| 03/28/2007 | EP1766082A2 Cog47 protein and s100beta gene polymorphism |
| 03/28/2007 | EP1766042A2 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 03/28/2007 | EP1766033A2 Genetically modified non-human mammals and cells |